References
- Hawkey PM. Pre-clinical experience with daptomycin. J Antimicrob Chemother 2008;62:iii7–14.
- Silverman JA, Mortin LI, VanPraagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis 2005;191: 2149–52.
- Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S. Eosinophilic pneumonia in patients treated with daptomycin. Drug Saf 2012;35:447–57.
- Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004;38:1673–81.
- Miller BA, Gray A, LeBlanc TW, Sexton DJ, Martin AR, and Thomas GS. Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases. Clin Infect Dis 2010; 50:e63–8.
- Kalogeropoulos AS, Tsiodras S, Loverdos D, Fanourgiakis P, Skoutelis A. Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature. J Med Case Rep 2011;5:13.
- Lal Y, Assimacopoulos AP. Two cases of daptomycin-induced eosinophilic pneumonia and chronic pneumonitis. Clin Infect Dis 2010;50:737–40.
- Hayes D Jr, Anstead MI, Kuhn RJ. Eosinophilic pneumonia induced by daptomycin. J Infect 2007;54:e211–3.
- Kakish E, Wiesner AM, Winstead PS. Acute respiratory failure due to daptomycin induced eosinophilic pneumonia. Respir Med CME 2008;1:235–7.
- Shinde A, Seifi A, DelRe S, Moustafa Hussein WH, Ohebsion J. Daptomycin-induced pulmonary infiltrates with eosinophilia. J Infect 2009;58:173–4.
- Rether C, Conen A, Grossenbacher M, Albrich WC. A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia. Infection 2011;39:583–5.
- Cobb E, Kimbrough RC, Nugent KM, Phy MP. Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin. Ann Pharmacother 2007;41:696–701.
- Janz DR, O’Neal HR Jr, Ely EW. Acute eosinophilic pneumonia: a case report and review of the literature. Crit Care Med 2009;37:1470–4.
- Mikerov AN, Gan X, Umstead TM, Miller L, Chinchilli VM, Phelps DS, Floros J. Sex differences in the impact of ozone on survival and alveolar macrophage function of mice after Klebsiella pneumoniae infection. Respir Res 2008;9:24.
- Walski M, Pokorski M, Antosiewicz J, Rekawek A, Frontczak-Baniewicz M, Jernajczyk U, Di Giulio C. Pulmonary surfactant: ultrastructural features and putative mechanisms of aging. J Physiol Pharmacol 2009;60(Suppl 5):121–5.
- Philit F, Etienne-Mastroïanni B, Parrot A, Guérin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002;166:1235–9.
- Solomon J, Schwarz M: Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 2006;27:192–7.
- Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012; 185:1004–14.